113.08
-1.72
(-1.50%)
At close: 5:35:51 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 24 | 22 | 36 | 35 |
| Avg. Estimate | 843.61M | 1.29B | 5.51B | 6.6B |
| Low Estimate | 796.5M | 1.06B | 5.27B | 5.96B |
| High Estimate | 1.04B | 1.56B | 5.72B | 7.2B |
| Year Ago Sales | 794.11M | 1.01B | 4.21B | 5.51B |
| Sales Growth (year/est) | 6.23% | 28.05% | 30.89% | 19.86% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| F3A.DE | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Baird: Outperform to Outperform | 4/15/2025 |
| Maintains | UBS: Buy to Buy | 4/14/2025 |
| Maintains | Susquehanna: Positive to Positive | 4/14/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/11/2025 |
| Maintains | B of A Securities: Buy to Buy | 4/8/2025 |
| Maintains | Guggenheim: Buy to Buy | 4/7/2025 |